High Tower Advisors, LLC Genprex, Inc. Transaction History

High Tower Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.74 - $1.1 $8,937 - $13,285	12,078 New	12,078 $11,000
Q2 2022 Aug 10, 2022	BUY	$1.28 - $2.31 $26,752 - $48,279	20,900 Added 186.96%	32,079 $44,000
Q1 2022 May 12, 2022	BUY	$1.82 - $3.5 $20,345 - $39,126	11,179 New	11,179 $25,000
Q4 2021 Feb 10, 2022	SELL	$1.21 - $2.7 $31,460 - $70,200	-26,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.59 - $3.36 $67,340 - $87,360	26,000 New	26,000 $70,000
Q4 2020 Feb 10, 2021	SELL	$3.03 - $5.51 $10,605 - $19,285	-3,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.9 - $4.29 $7,830 - $11,583	-2,700 Reduced 43.55%	3,500 $12,000
Q2 2020 Aug 10, 2020	BUY	$1.99 - $3.64 $1,988 - $3,636	999 Added 19.21%	6,200 $20,000
Q1 2020 May 21, 2020	BUY	$0.28 - $6.23 $1,456 - $32,402	5,201 New	5,201 $12,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.